Orion Biotech Opportunities Total Liabilities

Orion Biotech Opportunities (ORIA) currently reports a total liabilities of $8.3M as of December 2022. That compares with $15M in the prior-year period — down 44.9% year over year. Use the charts on this page to explore Orion Biotech Opportunities's total liabilities history and peer comparisons.

Orion Biotech Opportunities's total liabilities decreased from $15M to $8.3M — a 44.9% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orion Biotech Opportunities reported $8.3M in total liabilities as of December 2022. That compares with $15M in the prior-year period — down 44.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $8.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.